References
- Siegel RL, Miller KD, Jemal A: Cancer statistics, 2020. CA Cancer J Clin 2020; 70: 7–30. doi: 10.3322/caac.21590.
- Dong Y, Teufel A, Wang WP, Dietrich CF: Current opinion about hepatocellular carcinoma <10 mm. Digestion 2021; 102: 335–341. doi: 10.1159/000507923.
- Dong Y, Wang WP, Lee WJ, Meloni MF, Clevert DA, Chammas MC et al.: Hepatocellular carcinoma in the non-cirrhotic liver. Clin Hemorheol Microcirc 2022; 80: 423–436. doi: 10.3233/ch-211309.
- Anwanwan D, Singh SK, Singh S, Saikam V, vSingh R: Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer 2020; 1873: 188314. doi: 10.1016/j.bbcan.2019.188314.
- Petrowsky H, Fritsch R, Guckenberger M, De Oliveira ML, Dutkowski P, Clavien PA: Modern therapeutic approaches for the treatment of malignant liver tumours. Nat Rev Gastroenterol Hepatol 2020; 17: 755–772. doi: 10.1038/s41575-020-0314-8.
- Grazioli L, Ambrosini R, Frittoli B, Grazioli M, Morone M: Primary benign liver lesions. Eur J Radiol 2017; 95: 378–398. doi: 10.1016/j.ejrad.2017.08.028.
- Dietrich CF, Nolsoe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V et al.: Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EF-SUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol 2020; 46: 2579–2604. doi: 10.1016/j.ultrasmedbio.2020.04.030.
- Wang Y, Wang WP, Ding H, Huang BJ, Mao F, Xu ZZ: Resistance index in differential diagnosis of liver lesions by color doppler ultrasonography. World J Gastroenterol 2004; 10: 965–967. doi: 10.3748/wjg.v10.i7.965.
- Dietrich CF, Jedrzejczyk M, Ignee A: Sonographic assessment of splanchnic arteries and the bowel wall. Eur J Radiol 2007; 64: 202–212. doi: 10.1016/j. ejrad.2007.06.034.
- Ignee A, Boerner N, Bruening A, Dirks K, von Herbay A, Jenssen C et al.: Duplex sonography of the mesenteric vessels – a critical evaluation of inter-observer variability. Z Gastroenterol 2016; 54: 304–311. doi: 10.1055/s-0041-107544.
- Dietrich CF, Maddalena ME, Cui XW, Schreiber-Dietrich D, Ignee A: Liver tumor characterization – review of the literature. Ultraschall Med 2012; 33 Suppl 1: S3–10. doi: 10.1055/s-0032-1312897.
- Nahar N, Khan N, Chakraborty RK, Rima SZ, Ara R, Islam SM et al.: Color Doppler sonography and resistivity index in the differential diagnosis of hepatic neoplasm. Mymensingh Med J 2014; 23: 35–40.
- Chiorean L, Cui XW, Tannapfel A, Franke D, Stenzel M, Kosiak W et al.: Benign liver tumors in pediatric patients – Review with emphasis on imaging features. World J Gastroenterol 2015; 21: 8541–8561. doi: 10.3748/wjg.v21.i28.8541.
- Vidili G, Piscaglia F, Ainora ME, Solinas G, Sagrini E, Gianstefani A et al.: Focal nodular hyperplasia: new findings at Doppler ultrasonography. Eur Rev Med Pharmacol Sci 2020; 24: 12288–12295. doi: 10.26355/eurrev_202012_24020.
- Dong Y, Wang WP, Mao F, Zhang Q, Yang D, Tannapfel A et al.: Imaging features of fibrolamellar hepatocellular carcinoma with contrast-enhanced ultrasound. Ultraschall Med 2021; 42: 306–313. doi: 10.1055/a-1110-7124.
- Bernatik T, Seitz K, Blank W, Schuler A, Dietrich CF, Strobel D: Unclear focal liver lesions in contrast-enhanced ultrasonography – lessons to be learned from the DE-GUM multicenter study for the characterization of liver tumors. Ultraschall Med 2010; 31: 577–581. doi: 10.1055/s-0029-1245649.
- Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A: Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005; 78: 704–707. doi: 10.1259/bjr/88181612.